To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ERV3andZNF117TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
288 supporting clones for gene ERV3andZNF117 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001007253.3   .a -11 to 3254 1 to 3266 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 3266/3266
(100 %)
0 diff
(100 %id)
DA198800 brain .a -10 to 553 2 to 565   tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
FN158547 breast carcinoma .a 14 to 93 82 to 1     Submitted on the opposite strand 82/82
(100 %)
1 diff
(98.8 %id)
DA754533   .a 15 to 570 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DA774433 brain .a 15 to 580 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA809529 brain .a 15 to 587 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
CF994104 Human Placenta, placenta .a 36 to 723 28 to 713       686/717
(95 %)
15 diff
(98.0 %id)
DA440912 tongue, tumor tissue .a 44 to 578 2 to 536   capped   535/535
(100 %)
3 diff
(99.5 %id)
DA441585 tongue, tumor tissue .a 44 to 621 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA500166 brain .a 45 to 618 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA508542 brain .a 45 to 623 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
DA509881 brain .a 45 to 623 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA779605 brain .a 45 to 621 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA992899 synovial membrane tissue from rheumatioidarthritis .a 45 to 555 2 to 512   capped   511/511
(100 %)
1 diff
(99.9 %id)
DA436515 tongue, tumor tissue .a 46 to 621 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA787525 brain .a 46 to 613 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
AL698252 human skeletal muscle .a 47 to 468 1 to 422       422/422
(100 %)
4 diff
(99.1 %id)
DA863879 placenta .a 49 to 629 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA864086 placenta .a 49 to 642 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DA708895   .a 58 to 418 2 to 362   capped   361/361
(100 %)
2 diff
(99.5 %id)
DA393086 thalamus .a 61 to 652 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
DA393110 thalamus .a 61 to 652 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
BM354183 Islets of Langerhans, Pancreas .a 61 to 593 1 to 533       533/533
(100 %)
2 diff
(99.7 %id)
DA739622   .a 74 to 589 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
DB199748 trachea .a 75 to 660 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA436786 tongue, tumor tissue .a 77 to 661 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DA677433   .a 77 to 653 2 to 578   tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
DA756388   .a 77 to 621 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DA783908 brain .a 77 to 662 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA714211   .a 79 to 626 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
AK295189 brain .a 82 to 2800 1 to 2719 T90I C192Y C197S N481S N569S tiling clone,   2719/2719
(100 %)
8 diff
(99.8 %id)
DA249364 brain .a 83 to 668 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
DA411038 thalamus .a 86 to 652 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA806863 brain .a 86 to 639 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA450800 tongue, tumor tissue .a 223 to 782 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BF882678 lung_tumor .a 257 to 743 9 to 491       483/491
(98 %)
6 diff
(98.8 %id)
BX389809 Placenta Cot 25-normalized .a 612 to 1472 1 to 861       861/861
(100 %)
8 diff
(99.1 %id)
TI_1968232735   .a 679 to 1592 919 to 5   tiling clone,   915/1272
(71 %)
0 diff
(100 %id)
TI_1968232739   .a 679 to 1177 500 to 2       499/1191
(41 %)
0 diff
(100 %id)
TI_1968235655   .a 679 to 1500 243 to 1061     Submitted on the opposite strand 819/1220
(67 %)
6 diff
(99.6 %id)
DN991402 brain, whole brain .a 688 to 1261 1 to 574       574/574
(100 %)
8 diff
(98.7 %id)
DA629045 Kidney .a 789 to 1357 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
CR746358 brain, oligodendroglioma .a 857 to 1368 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
DA837892 placenta .a 944 to 1487 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA829361 placenta .a 947 to 1682 2 to 729   capped   728/728
(100 %)
23 diff
(96.9 %id)
AK074464 Human lung .a 987 to 3254 141 to 2408   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2268/2325
(97 %)
6 diff
(99.8 %id)
DA829649 placenta .a 1084 to 1829 2 to 751   capped   750/754
(99 %)
15 diff
(98.1 %id)
DA148209 amygdala .a 1129 to 1697 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA840001 placenta .a 1296 to 1858 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA849730 placenta .a 1345 to 1894 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
TI_1968232947   .a 1369 to 2448 1 to 1072       1072/1293
(82 %)
12 diff
(99.1 %id)
TI_1968231995   .a 1394 to 2442 1170 to 141       1030/1221
(84 %)
0 diff
(100 %id)
TI_2194696232   .a 1406 to 2442 1154 to 140       1015/1182
(85 %)
0 diff
(100 %id)
BE222728 brain, oligodendroglioma .a 1408 to 1979 571 to 1       571/577
(98 %)
7 diff
(98.8 %id)
AI032838 liver and spleen .a 1438 to 1754 554 to 239       316/560
(56 %)
0 diff
(100 %id)
DA845781 placenta .a 1453 to 1997 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
TI_1968232957   .a 1480 to 2448 9 to 975   tiling clone,   967/1240
(77 %)
9 diff
(99.3 %id)
TI_2194696337   .a 1576 to 2442 1006 to 142       865/1010
(85 %)
0 diff
(100 %id)
DB276216 uterus .a 1695 to 2244 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
R36418 placenta .a 1721 to 2069 1 to 360       360/360
(100 %)
16 diff
(95.6 %id)
DA841125 placenta .a 1729 to 2298 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
AA027781 placenta .a 1749 to 2270 1 to 514       514/582
(88 %)
26 diff
(95.6 %id)
H09927 whole brain .a 1763 to 2214 1 to 466     Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 466/466
(100 %)
17 diff
(96.4 %id)
BG572215 placenta .a 1798 to 2481 1 to 697       697/732
(95 %)
28 diff
(96.2 %id)
TI_157600837   .a 1842 to 2202 34 to 394     Submitted on the opposite strand 361/872
(41 %)
5 diff
(99.5 %id)
R31864 placenta .a 1848 to 2135 1 to 297       297/333
(89 %)
14 diff
(95.8 %id)
R18756 whole brain .a 1867 to 2223 1 to 372     Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 372/397
(93 %)
22 diff
(94.5 %id)
CR746882 skin .a 1869 to 2383 1 to 515       515/515
(100 %)
2 diff
(99.7 %id)
BG741949 skin .a 1870 to 2706 1 to 841       841/842
(99 %)
22 diff
(97.4 %id)
H25169 whole brain .a 1889 to 2363 1 to 489     Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 489/496
(98 %)
29 diff
(94.2 %id)
TI_1968232949   .a 1936 to 2449 18 to 531       514/1300
(39 %)
6 diff
(99.6 %id)
TI_1968232959   .a 1980 to 2449 16 to 483       468/1209
(38 %)
6 diff
(99.6 %id)
R85001 brain .a 2040 to 2185 13 to 157       145/157
(92 %)
6 diff
(96.2 %id)
AV705656 adrenal gland .a 2136 to 2731 1 to 595       595/637
(93 %)
16 diff
(97.5 %id)
AV702610 adrenal gland .a 2179 to 2844 1 to 661       661/663
(99 %)
17 diff
(97.5 %id)
AW955895   .a 2207 to 2715 667 to 164     Submitted on the opposite strand 504/699
(72 %)
0 diff
(100 %id)
DB278267 uterus .a 2225 to 2672 2 to 450   capped   449/449
(100 %)
5 diff
(98.9 %id)
BG698734 skin .a 2308 to 3218 1 to 957       957/957
(100 %)
89 diff
(90.8 %id)
BC063605 Skin, normal .a 2308 to 3252 1 to 946   available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 946/946
(100 %)
3 diff
(99.7 %id)
BG698660 skin .a 2308 to 3237 1 to 915   available from MGC,   915/920
(99 %)
42 diff
(95.5 %id)
BX352112 Placenta Cot 25-normalized .a 2365 to 3231 890 to 12       879/912
(96 %)
0 diff
(100 %id)
R77854 placenta .a 2465 to 2910 10 to 469   fully sequenced,   460/469
(98 %)
21 diff
(95.6 %id)
BF960223 nervous_normal .a 2479 to 2600 10 to 130       121/130
(93 %)
6 diff
(95.4 %id)
N56821 placenta .a 2577 to 2779 1 to 203       203/203
(100 %)
0 diff
(100 %id)
AI023916 liver and spleen .a 2600 to 3038 478 to 38       441/478
(92 %)
0 diff
(100 %id)
BX479205   .a 2633 to 2898 1 to 267       267/267
(100 %)
3 diff
(98.9 %id)
AW170423 cervix, tumor .a 2677 to 3252 577 to 1       577/577
(100 %)
2 diff
(99.7 %id)
BM706846 eye, optic nerve .a 2688 to 3252 7 to 572   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 566/572
(98 %)
3 diff
(99.5 %id)
AW025051 Kidney .a 2715 to 3254 540 to 1   tiling clone,   540/540
(100 %)
1 diff
(99.9 %id)
AW341004 carcinoid, lung .a 2720 to 3247 528 to 1       528/528
(100 %)
3 diff
(99.5 %id)
BF224243 carcinoid, lung .a 2720 to 3253 537 to 4       534/537
(99 %)
0 diff
(100 %id)
R81041 placenta .a 2728 to 3082 1 to 360       360/360
(100 %)
8 diff
(97.8 %id)
AI824590 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2728 to 3254 529 to 2       528/529
(99 %)
0 diff
(100 %id)
R77087 placenta .a 2729 to 2984 1 to 267   fully sequenced,   267/267
(100 %)
2 diff
(99.3 %id)
CA414211 Knee, Osteoarthritic Cartilage .a 2733 to 3252 538 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 520/529
(98 %)
3 diff
(99.5 %id)
BM273203 Islets of Langerhans, Pancreas .a 2746 to 3252 508 to 1       508/508
(100 %)
2 diff
(99.7 %id)
AI681000 carcinoid, lung .a 2752 to 3247 497 to 1       497/497
(100 %)
3 diff
(99.4 %id)
BM273027 Islets of Langerhans, Pancreas .a 2754 to 3252 500 to 1       500/500
(100 %)
2 diff
(99.6 %id)
BX112807 whole brain .a 2758 to 3252 510 to 15   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 496/496
(100 %)
3 diff
(99.4 %id)
AI697303 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2801 to 3252 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
AI479940 anaplastic oligodendroglioma, brain .a 2810 to 3254 455 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 445/445
(100 %)
0 diff
(100 %id)
H24353 whole brain .a 2826 to 3252 448 to 18   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 431/431
(100 %)
15 diff
(96.6 %id)
AI800291 Kidney .a 2837 to 3253 421 to 6       416/421
(98 %)
0 diff
(100 %id)
AI401070 Prostate .a 2838 to 3254 421 to 4       418/421
(99 %)
0 diff
(100 %id)
R78532 placenta .a 2846 to 3233 392 to 1       392/397
(98 %)
12 diff
(97.0 %id)
N32401 placenta .a 2848 to 3253 415 to 9       407/415
(98 %)
0 diff
(100 %id)
H09928 whole brain .a 2849 to 3252 417 to 11   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 407/407
(100 %)
11 diff
(97.3 %id)
AI224119 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2855 to 3252 417 to 20   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 398/398
(100 %)
3 diff
(99.3 %id)
R84958 brain .a 2861 to 3229 372 to 1       372/376
(98 %)
11 diff
(97.1 %id)
AA668401   .a 2879 to 3224 346 to 1       346/346
(100 %)
9 diff
(97.4 %id)
R77762 placenta .a 2882 to 3235 356 to 1   fully sequenced,   356/356
(100 %)
10 diff
(97.2 %id)
AA514392 colon .a 2886 to 3253 368 to 2       367/368
(99 %)
0 diff
(100 %id)
AI078475 liver and spleen .a 2921 to 3248 359 to 32   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 328/328
(100 %)
6 diff
(98.2 %id)
DB374546 placenta .a 2927 to 3252 324 to 1       324/329
(98 %)
7 diff
(97.9 %id)
R76915 placenta .a 2954 to 3242 293 to 1   fully sequenced,   293/293
(100 %)
4 diff
(98.7 %id)
R36140 placenta .a 2955 to 3249 306 to 5       302/307
(98 %)
0 diff
(100 %id)
AA702508 liver and spleen .a 2957 to 3234 277 to 1       277/278
(99 %)
9 diff
(96.8 %id)
AI420260 Prostate .a 2960 to 3253 300 to 6       295/300
(98 %)
0 diff
(100 %id)
AA469075 colon .a 2967 to 3253 286 to 1       286/286
(100 %)
4 diff
(98.7 %id)
R43076 whole brain .a 2995 to 3252 271 to 11   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 261/270
(96 %)
11 diff
(96.0 %id)
BU728173 eye, optic nerve .a 2997 to 3252 274 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 256/256
(100 %)
1 diff
(99.7 %id)
T29304 brain .a 3012 to 3213 1 to 202       202/204
(99 %)
2 diff
(99.1 %id)
AW949734   .a 3013 to 3252 1 to 240   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 240/240
(100 %)
1 diff
(99.6 %id)
AA634137   .a 3048 to 3252 205 to 1       205/205
(100 %)
3 diff
(98.6 %id)
DA852378 placenta .b 1 to 542 2 to 543   tiling clone, capped   542/542
(100 %)
3 diff
(99.5 %id)
CB990146 Human Placenta, placenta .b 9 to 615 27 to 635       609/721
(84 %)
18 diff
(97.6 %id)
DA436571 tongue, tumor tissue .b 11 to 584 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DA455953 tongue, tumor tissue .b 11 to 567 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
CF994831 Human Placenta, placenta .b 11 to 795 29 to 824       796/842
(94 %)
25 diff
(97.1 %id)
DA857632 placenta .b 13 to 546 2 to 535   capped   534/534
(100 %)
3 diff
(99.5 %id)
DA462211 tongue, tumor tissue .b 49 to 625 2 to 578   tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
DA831193 placenta .b 317 to 986 2 to 672   tiling clone, capped   671/674
(99 %)
5 diff
(99.3 %id)
M55422 placenta .b 2710 to 5583 1 to 2873   tiling clone,   2873/2873
(100 %)
10 diff
(99.7 %id)
NM_015852.3   .b 2710 to 9113 1 to 6404   RefSeq,   6404/6404
(100 %)
0 diff
(100 %id)
DB376732 placenta .b 2821 to 3391 566 to 1       566/569
(99 %)
34 diff
(94.1 %id)
DR000587 fetal brain .b 2826 to 3604 1 to 773   tiling clone,   773/773
(100 %)
14 diff
(98.2 %id)
BX459099 placenta .b 3093 to 4179 1 to 1079   tiling clone,   1079/1103
(97 %)
20 diff
(98.2 %id)
BM988753 lung, Lung Focal Fibrosis .b 3104 to 3397 1 to 293     Submitted on the opposite strand 293/296
(98 %)
10 diff
(96.7 %id)
AL699907 human skeletal muscle .b 3584 to 3977 1 to 394       394/413
(95 %)
5 diff
(98.8 %id)
CN362484 embryonic stem cells, cell lines H1, H7, andH9 .b 3677 to 4383 1 to 707       707/707
(100 %)
4 diff
(99.5 %id)
BF086449 placenta_normal .b 3739 to 4074 1 to 339       339/340
(99 %)
11 diff
(96.8 %id)
DR000505 fetal brain .b 3828 to 4491 1 to 665       665/669
(99 %)
9 diff
(98.7 %id)
BC034021 placenta .b 3868 to 5713 312 to 2157   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1846/2157
(85 %)
11 diff
(99.5 %id)
AL596612 human spinal cord .b 3870 to 4422 23 to 575   tiling clone,   553/575
(96 %)
6 diff
(99.0 %id)
M61867   .b 3897 to 4386 9 to 498       490/499
(98 %)
10 diff
(98.0 %id)
AL598300   .b 4116 to 4761 1 to 646       646/646
(100 %)
4 diff
(99.4 %id)
CN362485 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4149 to 4835 1 to 687       687/687
(100 %)
1 diff
(99.9 %id)
DA947670 Spleen .b 4464 to 5018 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BG223548 moderate to poorly differentiated invasivecarcinoma, tongue .b 4472 to 4684 1 to 212       212/246
(86 %)
7 diff
(97.2 %id)
BX952541   .b 4568 to 5231 1 to 664       664/664
(100 %)
0 diff
(100 %id)
DB109678 thymus .b 4618 to 5191 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA831015 placenta .b 4731 to 5340 2 to 610   tiling clone, capped   609/749
(81 %)
44 diff
(94.2 %id)
BF748343 breast_normal .b 4998 to 5361 1 to 362       362/364
(99 %)
4 diff
(99.0 %id)
CN280766 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 5024 to 5779 1 to 755       755/759
(99 %)
4 diff
(99.5 %id)
BG435048 placenta .b 5043 to 5712 1 to 677       677/802
(84 %)
20 diff
(97.6 %id)
CN280765 embryonic stem cells, DMSO-treated H9 cellline .b 5077 to 5772 9 to 705       697/705
(98 %)
3 diff
(99.6 %id)
CN280768 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 5148 to 5894 1 to 745       745/745
(100 %)
4 diff
(99.5 %id)
BG696505 skin .b 5539 to 6228 1 to 693   tiling clone,   693/694
(99 %)
11 diff
(98.5 %id)
CN280110 embryonic stem cells, DMSO-treated H9 cellline .b 5565 to 6135 1 to 571       571/571
(100 %)
10 diff
(98.3 %id)
AI792344   .b 5570 to 6259 22 to 712   tiling clone,   691/712
(97 %)
6 diff
(99.2 %id)
CN280767 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 5637 to 6375 1 to 738       738/738
(100 %)
5 diff
(99.4 %id)
BG624004 placenta .b 5672 to 5991 1 to 321       321/632
(50 %)
4 diff
(99.4 %id)
BE937857 testis_normal .b 5950 to 6284 10 to 343       334/343
(97 %)
6 diff
(98.3 %id)
TI_154093610   .b 5987 to 6826 946 to 104   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 843/967
(87 %)
24 diff
(97.6 %id)
CN274402 embryonic stem cells, DMSO-treated H9 cellline .b 6012 to 6371 1 to 361       361/361
(100 %)
8 diff
(97.8 %id)
CN280111 embryonic stem cells, DMSO-treated H9 cellline .b 6042 to 6753 1 to 712   tiling clone,   712/712
(100 %)
4 diff
(99.5 %id)
CA436327 Bone, Subchondral Bone .b 6084 to 6824 758 to 21   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 738/738
(100 %)
9 diff
(98.8 %id)
AI733621   .b 6125 to 6838 715 to 1       715/715
(100 %)
7 diff
(99.1 %id)
BX641347   .b 6198 to 6741 1 to 544   tiling clone,   544/544
(100 %)
1 diff
(99.9 %id)
AI049550   .b 6396 to 6836 441 to 1       441/441
(100 %)
3 diff
(99.4 %id)
DB376452 placenta .b 6402 to 6862 457 to 1       457/583
(78 %)
5 diff
(99.2 %id)
BF368253 placenta_normal .b 6423 to 6818 12 to 410       399/410
(97 %)
7 diff
(98.3 %id)
BI669874 brain, hypothalamus .b 6429 to 7026 1 to 598   tiling clone,   598/598
(100 %)
6 diff
(99.0 %id)
TI_44344408   .b 6433 to 7026 87 to 680       594/680
(87 %)
6 diff
(99.2 %id)
DA747100   .b 6498 to 7072 2 to 576   tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
CA388658 eye, RPE/choroid .b 6574 to 6839 1 to 266   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 266/266
(100 %)
0 diff
(100 %id)
BG570938 placenta .b 6645 to 7123 1 to 491       491/726
(67 %)
20 diff
(97.3 %id)
AW593623 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 6728 to 6844 117 to 1       117/125
(93 %)
0 diff
(100 %id)
CV569498 cornea, eye .b 6992 to 7604 1 to 613   tiling clone,   613/613
(100 %)
2 diff
(99.7 %id)
DA669180 esophagus .b 7020 to 7450 2 to 438   capped   437/437
(100 %)
6 diff
(98.7 %id)
CN310789 embryonic stem cells, DMSO-treated H9 cellline .b 7040 to 7736 1 to 699       699/699
(100 %)
5 diff
(99.3 %id)
AL138182 brain .b 7080 to 7544 1 to 467   tiling clone,   467/467
(100 %)
3 diff
(99.4 %id)
BG434173 placenta .b 7175 to 7927 1 to 753       753/753
(100 %)
20 diff
(97.4 %id)
BG573538 placenta .b 7240 to 8031 1 to 791       791/793
(99 %)
24 diff
(97.0 %id)
BI047968 stomach .b 7276 to 7732 473 to 20       454/473
(95 %)
0 diff
(100 %id)
BI047967 stomach .b 7279 to 7732 464 to 13       452/466
(96 %)
0 diff
(100 %id)
BM729293 eye, fetal eye .b 7326 to 7807 105 to 586       482/586
(82 %)
6 diff
(99.0 %id)
BI048128 stomach .b 7346 to 7713 368 to 2       367/368
(99 %)
0 diff
(100 %id)
AV705438 adrenal gland .b 7386 to 8110 1 to 719   tiling clone,   719/723
(99 %)
10 diff
(98.7 %id)
BG257220 embryonal carcinoma, cell line, testis .b 7387 to 8128 1 to 743       743/972
(76 %)
24 diff
(97.6 %id)
BG257481 embryonal carcinoma, cell line, testis .b 7388 to 8092 1 to 701       701/704
(99 %)
11 diff
(98.5 %id)
BG257391 embryonal carcinoma, cell line, testis .b 7388 to 8140 1 to 733       733/851
(86 %)
31 diff
(96.4 %id)
TI_151756480   .b 7393 to 8360 1035 to 95   tiling clone,   941/1043
(90 %)
0 diff
(100 %id)
AW956209   .b 7398 to 7971 1 to 575   tiling clone,   575/575
(100 %)
6 diff
(99.0 %id)
CV572782 cornea, eye .b 7495 to 8137 1 to 639       639/639
(100 %)
6 diff
(99.1 %id)
BG535611 lung .b 7514 to 8232 1 to 737       737/763
(96 %)
69 diff
(91.0 %id)
CB995246 placenta, pre-eclamptic placenta .b 7566 to 8355 21 to 808       788/815
(96 %)
6 diff
(99.3 %id)
BG570918 placenta .b 7580 to 8288 1 to 712       712/734
(97 %)
21 diff
(97.2 %id)
BQ022901 placenta .b 7687 to 8250 577 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 559/559
(100 %)
4 diff
(99.3 %id)
BF107006 placenta .b 7873 to 8536 1 to 642       642/810
(79 %)
23 diff
(97.2 %id)
AI022497 parathyroid gland, parathyroid tumor .b 7898 to 8352 457 to 10   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 448/448
(100 %)
4 diff
(99.2 %id)
BX097941 placenta .b 8035 to 8824 1 to 787       787/787
(100 %)
4 diff
(99.5 %id)
R27526 placenta .b 8035 to 8250 1 to 216       216/217
(99 %)
2 diff
(99.1 %id)
AA908361 ovary, serous adenocarcinoma .b 8047 to 8352 303 to 1       303/303
(100 %)
3 diff
(99.1 %id)
R79707 placenta .b 8069 to 8449 1 to 390       390/390
(100 %)
19 diff
(95.2 %id)
BX098709 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 8125 to 8538 425 to 15   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 411/411
(100 %)
5 diff
(98.8 %id)
CN360835 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 8125 to 8872 1 to 740   tiling clone,   740/740
(100 %)
5 diff
(99.4 %id)
AI886558 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 8220 to 8538 332 to 14   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 319/319
(100 %)
12 diff
(96.3 %id)
AI289295 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 8319 to 8824 506 to 1       506/524
(96 %)
7 diff
(98.7 %id)
T06148   .b 8343 to 8700 358 to 1   tiling clone,   358/358
(100 %)
1 diff
(99.8 %id)
FN094969 breast carcinoma .b 8383 to 8453 1 to 73       73/74
(98 %)
3 diff
(96.0 %id)
FN139951 breast carcinoma .b 8383 to 8454 1 to 75       75/76
(98 %)
2 diff
(97.4 %id)
R27038 placenta .b 8390 to 8624 1 to 230       230/235
(97 %)
7 diff
(97.1 %id)
AW166859 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 8400 to 8843 449 to 6       444/449
(98 %)
0 diff
(100 %id)
N68251 cochlea, ear .b 8406 to 8839 442 to 1       442/442
(100 %)
12 diff
(97.3 %id)
DB322191 esophagus .b 8433 to 8995 563 to 1       563/563
(100 %)
1 diff
(99.9 %id)
DB325006   .b 8449 to 9001 553 to 1       553/553
(100 %)
0 diff
(100 %id)
BU954149 mixed (pool of 40 RNAs) .b 8454 to 8825 1 to 366       366/964
(37 %)
8 diff
(99.2 %id)
CN360836 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 8465 to 8839 1 to 375   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 375/375
(100 %)
0 diff
(100 %id)
R66874 placenta .b 8482 to 8861 1 to 379   fully sequenced,   379/379
(100 %)
22 diff
(94.2 %id)
R66323 placenta .b 8482 to 8795 1 to 312       312/317
(98 %)
7 diff
(97.8 %id)
AF075025   .b 8483 to 9113 1 to 625   tiling clone,   625/625
(100 %)
4 diff
(99.4 %id)
AW024612 Kidney .b 8494 to 8998 530 to 7       524/530
(98 %)
0 diff
(100 %id)
AW473274 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 8509 to 9001 492 to 1       492/492
(100 %)
1 diff
(99.8 %id)
BQ024496 placenta .b 8523 to 9001 491 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 473/473
(100 %)
3 diff
(99.4 %id)
AI813929 adenocarcinoma, Pancreas .b 8525 to 9005 495 to 15   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 481/481
(100 %)
0 diff
(100 %id)
R79708 placenta .b 8589 to 8831 243 to 1       243/247
(98 %)
0 diff
(100 %id)
AW058673 pooled .b 8592 to 9112 521 to 1       521/521
(100 %)
4 diff
(99.3 %id)
AI888942 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 8598 to 8998 401 to 1       401/401
(100 %)
17 diff
(95.8 %id)
R25669 placenta .b 8617 to 8843 227 to 1       227/227
(100 %)
2 diff
(99.2 %id)
AA156112   .b 8747 to 9109 366 to 4   tiling clone,   363/366
(99 %)
0 diff
(100 %id)
AI571044 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 8758 to 9005 261 to 14   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 248/248
(100 %)
1 diff
(99.6 %id)
R67465.
matches multiple genes
placenta .b 8780 to 9113 339 to 1     also hits gene snorpo 339/343
(98 %)
8 diff
(97.7 %id)
R67962 placenta .b 8831 to 9095 268 to 1   fully sequenced,   268/268
(100 %)
5 diff
(98.2 %id)
FN153350 breast carcinoma .b 8930 to 8995 1 to 68       68/68
(100 %)
2 diff
(97.1 %id)
M27879   .c 1 to 1375 9 to 1383 Q163H G315D Q320L T326K R329V ... tiling clone,   1375/1389
(98 %)
42 diff
(97.0 %id)
BX647584 adipose .c 1185 to 6380 1 to 5184   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 5184/5184
(100 %)
20 diff
(99.7 %id)
DA859740 placenta .c 2132 to 2739 2 to 604   tiling clone, capped   603/603
(100 %)
4 diff
(99.4 %id)
BX641922   .c 2505 to 3012 1 to 503   tiling clone,   503/503
(100 %)
6 diff
(98.9 %id)
R36361 placenta .c 4095 to 4477 1 to 388   tiling clone,   388/390
(99 %)
8 diff
(98.0 %id)
BX641923   .c 4501 to 5260 760 to 1       760/760
(100 %)
1 diff
(99.9 %id)
AA665162 alveolar rhabdomyosarcoma .c 4642 to 4927 1 to 286       286/286
(100 %)
8 diff
(97.3 %id)
DB328996 placenta .c 4767 to 5270 504 to 1       504/504
(100 %)
1 diff
(99.9 %id)
BU568736 testis .c 4947 to 5702 1 to 766       766/766
(100 %)
20 diff
(97.4 %id)
T05168   .c 5997 to 6313 318 to 2   tiling clone,   317/318
(99 %)
0 diff
(100 %id)
R35988 placenta .c 6200 to 6385 188 to 3       186/188
(98 %)
0 diff
(100 %id)
BF212345 bone marrow, from chronic myelogenous leukemia .d 1 to 514 1 to 516 I31M R33D S34P T35Q L64S ... tiling clone,   516/516
(100 %)
16 diff
(96.9 %id)
DA256611 caudate nucleus .e 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
2 diff
(99.7 %id)
CR608597 fetal brain .e 17 to 1853 1 to 1837 exact tiling clone,   1837/1837
(100 %)
0 diff
(100 %id)
BX419624 brain, fetal brain .e 17 to 1037 1 to 1010 exact fully sequenced,   1010/1010
(100 %)
11 diff
(99.0 %id)
BI834213 pooled pancreas and spleen .e 611 to 1450 1 to 843       843/843
(100 %)
18 diff
(97.9 %id)
TI_57163673   .e 611 to 1450 35 to 877       843/877
(96 %)
18 diff
(98.0 %id)
BX413290 brain, fetal brain .e 1010 to 1853 844 to 1   fully sequenced,   844/844
(100 %)
25 diff
(97.1 %id)
DA411494 thalamus .e 1214 to 1768 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BF446286 Prostate .e 1313 to 1849 548 to 12   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 537/537
(100 %)
2 diff
(99.7 %id)
AL047042 uterus .e 1680 to 1860 1 to 181   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 181/181
(100 %)
0 diff
(100 %id)
DA384653 thalamus .f-u 1 to 572 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
DA372635 thalamus .f-u 15 to 562 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BX107844 Prostate .f-u 42 to 538 1 to 497       497/497
(100 %)
1 diff
(99.8 %id)
BF966157 brain, hippocampus .f-u 43 to 748 1 to 696       696/843
(82 %)
32 diff
(96.3 %id)
DA006833   .f-u 45 to 621 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BE247317 leukopheresis .f-u 47 to 256 1 to 210       210/210
(100 %)
5 diff
(97.7 %id)
DB470708 hippocampus .f-u 51 to 282 1 to 232       232/240
(96 %)
7 diff
(97.1 %id)
BM922542 leukocyte .f-u 53 to 1118 8 to 1083       1076/1095
(98 %)
30 diff
(97.3 %id)
TI_57200641   .f-u 57 to 1039 90 to 1089       1000/1101
(90 %)
55 diff
(95.1 %id)
BG399657 Kidney .f-u 59 to 711 1 to 646       646/856
(75 %)
36 diff
(95.8 %id)
BI821489 pooled brain, lung, testis .f-u 61 to 1039 1 to 996       996/1008
(98 %)
54 diff
(94.7 %id)
CR615024 Placenta Cot 25-normalized .f-u 63 to 1814 1 to 1752 exact tiling clone,   1752/1752
(100 %)
0 diff
(100 %id)
BX360132 Placenta Cot 25-normalized .f-u 63 to 958 1 to 883   fully sequenced,   883/883
(100 %)
12 diff
(98.7 %id)
AA332777 Embryo, 8 weeks .f-u 67 to 261 16 to 211       196/213
(92 %)
7 diff
(96.8 %id)
AI685512 Prostate .f-u 82 to 664 583 to 1       583/583
(100 %)
8 diff
(98.7 %id)
AA652729 normal prostate, Prostate .f-u 88 to 664 576 to 1       576/582
(98 %)
13 diff
(97.8 %id)
BX360131 Placenta Cot 25-normalized .f-u 928 to 1814 878 to 1 L33F A40X V46I L53X Q79X ... fully sequenced,   878/878
(100 %)
12 diff
(98.7 %id)
BF966928 brain, hippocampus .f-u 972 to 1776 829 to 20       810/861
(94 %)
0 diff
(100 %id)
AW868281 stomach_normal .f-u 991 to 1284 311 to 20       292/311
(93 %)
0 diff
(100 %id)
N58327 liver and spleen .f-u 1226 to 1590 1 to 370     Submitted on the opposite strand 370/395
(93 %)
9 diff
(97.8 %id)
H65481 liver and spleen .f-u 1273 to 1668 1 to 402     Submitted on the opposite strand 402/402
(100 %)
6 diff
(98.6 %id)
N77694 liver and spleen .f-u 1321 to 1845 537 to 1 L2A Q3V C4Y L5A V6T ...   Submitted on the opposite strand 537/541
(99 %)
17 diff
(96.9 %id)
DB310980 thalamus .f-u 1352 to 1844 493 to 1 exact     493/493
(100 %)
1 diff
(99.8 %id)
AA716681 heart .f-u 1402 to 1844 443 to 1 L33F     443/443
(100 %)
1 diff
(99.8 %id)
AI361749 B-cell, chronic lymphotic leukemia .f-u 1404 to 1845 443 to 1 K28M C31R     443/443
(100 %)
5 diff
(98.9 %id)
DB539001 hippocampus .f-u 1409 to 1844 1 to 435 S26T W48L G49V T50L L51F ...   Submitted on the opposite strand 435/435
(100 %)
6 diff
(98.7 %id)
BE246003 leukopheresis .f-u 1423 to 1837 415 to 1 L33F R42S W83K W84K     415/415
(100 %)
8 diff
(98.1 %id)
H64888 liver and spleen .f-u 1462 to 1846 390 to 1 L2C Q3Y C4X L5V V6* tiling clone, Submitted on the opposite strand 390/390
(100 %)
5 diff
(98.8 %id)
AA747865 pooled germ cell tumors .f-u 1525 to 1844 320 to 1       320/320
(100 %)
0 diff
(100 %id)
AK097499 testis .g -8 to 1720 1 to 1727   tiling clone, available from FLJ,   1727/1727
(100 %)
4 diff
(99.8 %id)
DB033275 testis .g 1 to 501 10 to 511   capped   510/510
(100 %)
2 diff
(99.7 %id)
BG494179 lung, mucoepidermoid carcinoma .g 47 to 525 1 to 485   tiling clone,   485/863
(56 %)
14 diff
(98.4 %id)
BG957798 colon .g 227 to 498 1 to 273   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 273/273
(100 %)
8 diff
(97.1 %id)
CD298606 Blood vessels - aorta, basilar and artery .g 658 to 1299 1 to 651       651/742
(87 %)
21 diff
(97.2 %id)
DB337218 testis .g 1189 to 1720 533 to 1       533/540
(98 %)
4 diff
(99.3 %id)
BF961069 nervous_normal .h 1 to 384 14 to 397   tiling clone,   384/397
(96 %)
6 diff
(98.5 %id)
DA508159 brain .h 52 to 633 2 to 583 exact tiling clone, capped   582/582
(100 %)
3 diff
(99.5 %id)
AA923156 carcinoid, lung .h 285 to 778 492 to 1 exact     492/492
(100 %)
2 diff
(99.6 %id)
BE644743 carcinoid, lung .h 298 to 776 491 to 13 exact tiling clone, AAA   479/479
(100 %)
0 diff
(100 %id)
AV708107 adrenal gland .h 316 to 684 1 to 369       369/369
(100 %)
0 diff
(100 %id)
AI797021 carcinoid, lung .h 337 to 778 448 to 7       442/448
(98 %)
0 diff
(100 %id)
AI302746 carcinoid, lung .h 383 to 778 402 to 7       396/402
(98 %)
0 diff
(100 %id)
AW138514   .h 450 to 778 344 to 16       329/344
(95 %)
0 diff
(100 %id)
AI868243   .h 479 to 776 298 to 1       298/298
(100 %)
0 diff
(100 %id)
BF110863 carcinoid, lung .h 513 to 776 276 to 13   AAA   264/264
(100 %)
0 diff
(100 %id)
DA861799 placenta .h 717 to 1283 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BQ015591 placenta .i 1 to 628 637 to 18 exact tiling clone, AAA Suspected internal deletion, possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 620/620
(100 %)
1 diff
(99.9 %id)
BG534734 lung .j 1 to 474 3 to 486 A30C G31R I32Y G33W R34E ... tiling clone,   486/544
(89 %)
46 diff
(91.6 %id)
BM718230 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 10 to 216 1 to 207   AAA   207/207
(100 %)
0 diff
(100 %id)
T28288 colon, embryo .j 44 to 226 1 to 183   tiling clone,   183/183
(100 %)
0 diff
(100 %id)
F27725 pectoral muscle (after mastectomy) .k 1 to 356 1 to 356 exact tiling clone, AAA   356/356
(100 %)
1 diff
(99.8 %id)
AV706536 adrenal gland Gene ERV3andZNF117, variant not shown         Suspected internal deletion, this clone was ignored    
BX361372 Placenta Cot 25-normalized Gene ERV3andZNF117, variant not shown         Suspected internal deletion, this clone was ignored    
DB354894 whole embryo, mainly head Gene ERV3andZNF117, variant not shown              
DA568384 whole embryo, mainly head Gene ERV3andZNF117, variant not shown       capped      
AA449091   Gene ERV3andZNF117, variant not shown              
AA449523   Gene ERV3andZNF117, variant not shown              
DR422622 eye, Pterygium Gene ERV3andZNF117, variant not shown         Suspected internal deletion, this clone was ignored    
DA689243   Gene ERV3andZNF117, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB000489 breast, tumor tissue Gene ERV3andZNF117, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC